Shawn A. Williams

The Apple China Claim

In re Apple Inc. Securities Litigation centered on Tim Cook’s statements during a November 1, 2018 earnings call about Greater China. Investors alleged that the statements concealed pressure on iPhone demand and that Apple reduced production four days later. On January 2, 2019, Apple announced that quarterly revenue would fall as much as $9 billion below its prior guidance, attributing the shortfall largely to economic weakness and lower iPhone sales in Greater China. Apple’s share price fell more than nine percent.

Norfolk County Council, as administering authority of the Norfolk Pension Fund, served as lead plaintiff. Williams and the Robbins Geller team developed the China-related claim through factual and expert discovery, class certification, summary judgment, and preparation for trial.

After assuming leadership of the action, Williams’s team narrowed the proposed class period and the alleged misrepresentation to a focused set of China statements. That choice concentrated the proof on the words spoken, the information then available, the surrounding statements, and the connection between the later disclosure and investor loss.

On February 4, 2022, the court certified a class of purchasers or acquirers of Apple common stock. After the lead plaintiff supplied additional analysis concerning options investors, the court modified the class on March 28, 2023 to include qualifying call-option buyers and put-option sellers.

The narrower merits theory and broader class definition addressed different problems: one concentrated the evidence on the China statements, and the other included qualifying options transactions within the same market claim. Williams’s team supported both choices with the evidentiary record and the governing class-action rules.

Summary Judgment and Trial Preparation

Williams argued the lead plaintiff’s opposition to Apple’s summary-judgment motion. His argument addressed whether the China statement was false or misleading, whether Cook acted with the state of mind required by federal securities law, whether the challenged statement caused investor losses, competing explanations for the price decline, expert opinions, and extensive factual exhibits.

The opposition organized competing expert opinions, a response to Apple’s assertedly undisputed facts, and the supporting exhibits around the issues a jury would decide. Williams connected that record to falsity, scienter, and loss causation without asking the court to resolve factual disputes reserved for jurors.

On June 26, 2023, the court denied Apple’s motion. It held that the evidence was sufficient for a jury to resolve the disputed issues, including falsity, scienter, and loss causation.

The court later set a September 9, 2024 jury trial and directed the parties to exchange and submit witness lists, motions in limine, proposed jury instructions, and other pretrial materials.

The Settlement

Apple agreed to create a $490 million settlement fund while continuing to deny liability. The court granted preliminary approval on June 3, 2024 and final approval on September 18, 2024. In the final-approval order, the court credited counsel’s “skill and strategic vision” in securing the recovery.

The final order confirmed the settlement class, approved the allocation process for eligible stock and options investors, entered judgment, and awarded $110.45 million in attorney fees and costs plus interest.

Medtronic

The Medtronic securities action concerned allegations that the company participated in drafting and editing medical-journal articles about INFUSE while the publications underreported adverse events and did not fully disclose financial ties to physician authors.

The district court entered summary judgment for the defendants after finding the federal claims untimely. In December 2016, the Eighth Circuit vacated that judgment and remanded the action, holding that reasonably diligent investors could not have discovered facts sufficient to plead scienter more than two years before filing suit.

An October 2012 Senate Finance Committee report described Medtronic’s alleged involvement in drafting, editing, and shaping the articles, including a recommendation against publishing a complete list of adverse events. The Eighth Circuit held that the investors filed within the two-year limitations period and that their scheme-liability theory was not barred as a matter of law.

After remand, Williams’s team defeated a renewed summary-judgment motion, then led the action through class certification and preparation for trial. The court approved a $43 million settlement and entered final judgment in December 2018.

Consumer Biometric Privacy Litigation

Williams was among lead counsel in In re Facebook Biometric Information Privacy Litigation, which challenged Facebook’s creation and storage of face templates under the Illinois Biometric Information Privacy Act. The case advanced through class certification, appellate review, summary judgment, and trial preparation before the court approved a $650 million settlement for Facebook users in 2021.

Williams’s work included litigation over technical and legal questions concerning facial-recognition systems, Article III injury, and the location of the challenged biometric processing. The matter was a consumer privacy class action, separate from his investor-securities docket.

Additional Investor Matters

Williams’s investor work has involved initial public offerings, accounting treatment, product disclosures, customer-account practices, and corporate reporting.

Williams served as lead counsel in the Alibaba securities action. Investors alleged that the company’s 2014 offering materials omitted known counterfeiting problems and a pre-offering meeting at which Chinese regulators directed Alibaba to address sales of counterfeit and trademark-infringing goods. A California court approved a $75 million settlement in May 2019.

He led Robbins Geller’s investigation and complaint work in the Wells Fargo investor action concerning unauthorized customer accounts, which produced a $480 million settlement.

Williams’s other investor matters include an $84 million MetLife settlement, a $75 million Krispy Kreme settlement, a $38 million Cadence Design Systems settlement, and a $33 million Prudential settlement, together with shareholder derivative matters seeking monetary and governance relief.

Trial Background and Firm Leadership

Williams spent five years in the Manhattan District Attorney’s Office and tried more than twenty cases to New York City juries.

That jury background supplies a practical method for converting a large discovery record into trial proof: identify which witnesses establish each event, arrange documents in a sequence jurors can follow, anticipate credibility challenges, and present technical evidence without distorting it.

Williams has described the firm’s trial posture in direct terms: when it says it is preparing for trial, “we really mean it.”

He joined the firm that became Robbins Geller in 2000 and later became a founding partner. He manages its San Francisco office and serves on the Management Committee.

Williams earned his J.D. from the University of Illinois in 1995 and his B.A. from the State University of New York at Albany in 1991. He is admitted in California and New York.